Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel versus Aspirin in Chronic Heart Failure
ISRCTN13415258Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) comparing Clopidogrel 75 mg daily with Aspirin 75 mg daily (2 arms). Primary endpoint: All-cause mortality. Started Feb 2011; status: terminated.
02
Drugs
clopidogrelaspirin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ISRCTN13415258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13415258.